- Home
- BSX vs BMY Comparison
BSX vs BMY Comparison
Compare BSX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSX | BMY |
|---|---|---|
| Founded | 1979 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8B | 95.0B |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | BSX | BMY |
|---|---|---|
| Price | $95.89 | $54.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 13 |
| Target Price | ★ $125.88 | $56.31 |
| AVG Volume (30 Days) | 10.5M | ★ 17.5M |
| Earning Date | 02-04-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | ★ 54.68 | N/A |
| EPS | 1.87 | ★ 2.97 |
| Revenue | $19,349,000,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $21.05 | $0.23 |
| Revenue Next Year | $11.43 | N/A |
| P/E Ratio | $51.57 | ★ $18.40 |
| Revenue Growth | ★ 21.61 | 1.26 |
| 52 Week Low | $85.98 | $42.52 |
| 52 Week High | $109.50 | $63.33 |
Technical Indicators
Market Signals| Indicator | BSX | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 67.69 |
| Support Level | $95.20 | $53.09 |
| Resistance Level | $97.27 | $54.86 |
| Average True Range (ATR) | 2.09 | 1.15 |
| MACD | 0.32 | 0.13 |
| Stochastic Oscillator | 62.30 | 85.95 |
Price Performance
Historical ComparisonAbout BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.